Publications by authors named "Ana M Badia-Tejero"
Article Synopsis
- The study evaluated the safety and effectiveness of isavuconazole in treating non-neutropenic patients with invasive fungal infections (IFIs) across 12 university hospitals from 2018 to 2022.
- A total of 238 cases were analyzed, with aspergillosis being the most common infection, and only 5.9% of patients experienced toxic effects, mostly related to liver issues.
- The treatment showed a successful clinical response in about 50.5% of patients after 12 weeks, indicating isavuconazole is a viable option for this patient group.
Objectives: to assess the current epidemiology, antibiotic therapy and outcomes of onco- hematological patients with bacteremic skin and soft-tissue infections (SSTIs), and to identify the risk factors for Gram-negative bacilli (GNB) infection and for early and overall mortality.
Methods: episodes of bacteremic SSTIs occurring in cancer patients at two hospitals were prospectively recorded and retrospectively analyzed.
Results: Of 164 episodes of bacteremic SSTIs, 53% occurred in patients with solid tumors and 47% with hematological malignancies.
Article Synopsis
- Type 2 diabetes mellitus (DM) in older adults shows different characteristics compared to younger populations, increasing risks of disability and cognitive issues.
- A study analyzed older adults (75+) over two years to assess functional and cognitive impairments in those with and without DM, involving 1611 participants.
- Results showed similar rates of impairment (9.6%) between both groups, with female gender, history of stroke, and greater dependency in daily activities being significant factors for disability in those with DM.
: We aimed to assess the incidence, etiology and outcomes of catheter-related bloodstream infection (CRBSI) in onco-hematological patients, to assess the differences between patients with hematological malignancies (HMs) and solid tumors (STs) and to identify the risk factors for Gram-negative (GN) CRBSI. : All consecutive episodes of BSI in adult cancer patients were prospectively collected (2006-2020). The etiology of CRBSI was analyzed in three different 5-year periods.
View Article and Find Full Text PDF